Name
Inside an "Advance of the Year" with Bristol-Myers Squibb and Dr. Siddhartha Mukherjee. Partner Talk.
Date & Time
Tuesday, November 1, 2016, 2:00 PM - 2:40 PM
Description
Civic Hall, 156 Fifth Avenue, New York, NY 10010
Bristol-Myers Squibb’s Chief Commercial Officer Murdo Gordon is working with Pulitzer Prize-winning author and leading cancer researcher Siddhartha Mukherjee for a conversation on the fast-advancing field of Immuno-Oncology— a type of cancer treatment that targets the body’s immune system. Named the “Advance of the Year” in cancer care*, Immuno-Oncology is impacting the treatment experience for everyone from healthcare providers and researchers to patients and their families. Learn about what the future holds for this game-changing medical field from the company that’s leading it forward.
*Named by the American Society of Clinical Oncology
*Named by the American Society of Clinical Oncology
Session
Inside an "Advance of the Year" with Bristol-Myers Squibb and Dr. Siddhartha Mukherjee
Partner Talk
Featuring MURDO GORDON, Vice President and Chief Commercial Officer, Bristol-Myers Squibb and SIDDHARTHA MUKHERJEE, physician, scientist, and writer
Partner Talk
Featuring MURDO GORDON, Vice President and Chief Commercial Officer, Bristol-Myers Squibb and SIDDHARTHA MUKHERJEE, physician, scientist, and writer
Session Type
DONT USE - CIVIC HALL
Theme
Leadership and Inclusion, Tech
Location
Civic Hall, 156 Fifth Avenue, New York, NY 10010
Civic Hall
Bristol-Myers Squibb’s Chief Commercial Officer Murdo Gordon is working with Pulitzer Prize-winning author and leading cancer researcher Siddhartha Mukherjee for a conversation on the fast-advancing field of Immuno-Oncology— a type of cancer treatment that targets the body’s immune system. Named the “Advance of the Year” in cancer care*, Immuno-Oncology is impacting the treatment experience for everyone from healthcare providers and researchers to patients and their families. Learn about what the future holds for this game-changing medical field from the company that’s leading it forward.
*Named by the American Society of Clinical Oncology